Healthcare -
Biotechnology - NASDAQ - US
$ 1.04
-9.48 %
$ 104 M
Market Cap
-0.85
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Alector, Inc.
| Revenue | 101 M |
| Cost Of Revenue | 8.84 M |
| Gross Profit | 91.7 M |
| Operating Expenses | 246 M |
| Operating Income | -145 M |
| Other Expenses | -25.9 M |
| Net Income | -119 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 100.6 | 97.1 | 133.6 | 207.1 | 21.1 | 21.2 | 27.7 | 3.7 | 0.4 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 8.8 | 192.1 | 8.5 | 189.4 | 156.9 | 100.5 | 73.0 | 29.9 | 13.7 |
| Gross Profit | 91.7 | (95.1) | 125.1 | 17.7 | (135.8) | (79.3) | (45.4) | (26.2) | (13.3) |
| OPERATING INCOME | |||||||||
| Operating Expenses | 245.6 | 248.8 | 271.5 | 244.4 | 216.3 | 135.6 | 85.0 | 36.4 | 15.5 |
| Selling, General and Administrative Expenses | 59.6 | 56.7 | 61.0 | 55.0 | 59.4 | 35.1 | 11.9 | 6.5 | 1.9 |
| Research and Development Expenses | 185.9 | 192.1 | 210.4 | 189.4 | 156.9 | 100.5 | 73.0 | 29.9 | 13.7 |
| Operating Income | (145.0) | (151.7) | (137.8) | (37.4) | (195.2) | (114.4) | (57.3) | (32.7) | (15.1) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 26.1 | 26.6 | 7.8 | 1.0 | 4.9 | 9.0 | 5.0 | 0.2 | 22 K |
| Pre-Tax Income | (118.9) | (125.2) | (130.1) | (36.3) | (190.2) | (105.4) | (52.2) | (32.5) | (15.1) |
| NET INCOME | |||||||||
| Tax Provision | 0.1 | 5.2 | 3.3 | (8.3) | (7.3) | (5.6) | 5.0 | 0 | 0 |
| Net Income | (119.0) | (130.4) | (133.3) | (28.0) | (183.0) | (99.8) | (52.2) | (32.5) | (15.1) |
| EPS | 1.23 | 1.56 | 1.62 | 0.35 | 2.35 | 1.62 | 0.76 | 0.63 | 0.29 |